Terms: = Bone cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx
70 results:
1. Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms.
Pritchard JE; Pearce JE; Snoeren IAM; Fuchs SNR; Götz K; Peisker F; Wagner S; Benabid A; Lutterbach N; Klöker V; Nagai JS; Hannani MT; Galyga AK; Sistemich E; Banjanin B; Flosdorf N; Bindels E; Olschok K; Biaesch K; Chatain N; Bhagwat N; Dunbar A; Sarkis R; Naveiras O; Berres ML; Koschmieder S; Levine RL; Costa IG; Gleitz HFE; Kramann R; Schneider RK
Cell Rep; 2024 Jan; 43(1):113608. PubMed ID: 38117649
[TBL] [Abstract] [Full Text] [Related]
2. Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype.
Vaghjiani VG; Cochrane CR; Jayasekara WSN; Chong WC; Szczepny A; Kumar B; Martelotto LG; McCaw A; Carey K; Kansara M; Thomas DM; Walkley C; Mudge S; Gough DJ; Downie PA; Peacock CD; Matsui W; Watkins DN; Cain JE
Oncogene; 2023 Nov; 42(47):3529-3541. PubMed ID: 37845394
[TBL] [Abstract] [Full Text] [Related]
3. Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.
Kresbach C; Holst L; Schoof M; Leven T; Göbel C; Neyazi S; Tischendorf J; Loose C; Wrzeszcz A; Yorgan T; Rutkowski S; Schüller U
Neuro Oncol; 2024 Apr; 26(4):609-622. PubMed ID: 37767814
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of Surgical Outcomes of Petroclival Meningiomas with Clinicoradiologic Parameters and Molecular and Chromosomal Alterations.
Sharma R; Singh J; Katiyar V; Narwal P; Suri V; Raheja A; Suri A
World Neurosurg; 2023 Mar; 171():e837-e845. PubMed ID: 36587896
[TBL] [Abstract] [Full Text] [Related]
5. Rapid and Automated Semiconductor-Based Next-Generation Sequencing for Simultaneous Detection of Somatic DNA and RNA Aberrations in Myeloid Neoplasms.
Sande CM; Wu R; Yang G; Sussman RT; Bigdeli A; Rushton C; Chitturi A; Patel J; Szankasi P; Morrissette JJD; Lim MS; Elenitoba-Johnson KSJ
J Mol Diagn; 2023 Feb; 25(2):87-93. PubMed ID: 36503148
[TBL] [Abstract] [Full Text] [Related]
6. The PROTAC selectively degrading Bcl-x
Zhang S; Chen Y; Xu Z; Yang J; Sun R; Wang J; Sun Y; Jiang B; Yang X; Tan W
Theranostics; 2022; 12(17):7476-7490. PubMed ID: 36438482
[No Abstract] [Full Text] [Related]
7. Hedgehog signalling in bone and osteoarthritis: the role of smoothened and cholesterol.
Smith AE; Sigurbjörnsdóttir ES; Steingrímsson E; Sigurbjörnsdóttir S
FEBS J; 2023 Jun; 290(12):3059-3075. PubMed ID: 35305060
[TBL] [Abstract] [Full Text] [Related]
8. Differential gene expression analysis for osteosarcoma lung metastases.
Liu F; Pang X; Yu Z; Wang K
Cancer Biomark; 2022; 33(3):379-387. PubMed ID: 34511489
[TBL] [Abstract] [Full Text] [Related]
9. Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR/S6K1 signaling cascade.
Wang W; Yan T; Guo W; Niu J; Zhao Z; Sun K; Zhang H; Yu Y; Ren T
Cell Death Differ; 2021 Jul; 28(7):2221-2237. PubMed ID: 33637972
[TBL] [Abstract] [Full Text] [Related]
10. Hedgehog Signaling: Implications in cancers and Viral Infections.
Iriana S; Asha K; Repak M; Sharma-Walia N
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494284
[TBL] [Abstract] [Full Text] [Related]
11. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas.
Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE
Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854
[TBL] [Abstract] [Full Text] [Related]
12. Maxillary Ameloblastoma: A Review With Clinical, Histological and Prognostic Data of a Rare Tumor.
Evangelou Z; Zarachi A; Dumollard JM; Peoc'h M; Komnos I; Kastanioudakis I; Karpathiou G
In Vivo; 2020; 34(5):2249-2258. PubMed ID: 32871747
[TBL] [Abstract] [Full Text] [Related]
13. A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
Martinez NL; Khanna O; Farrell CJ
Chin Clin Oncol; 2020 Dec; 9(6):75. PubMed ID: 32819111
[TBL] [Abstract] [Full Text] [Related]
14. The inhibition of microRNA-326 by SP1/HDAC1 contributes to proliferation and metastasis of osteosarcoma through promoting smo expression.
Huang JH; Xu Y; Lin FY
J Cell Mol Med; 2020 Sep; 24(18):10876-10888. PubMed ID: 32743904
[TBL] [Abstract] [Full Text] [Related]
15. Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma.
Kondo S; Ota A; Ono T; Karnan S; Wahiduzzaman M; Hyodo T; Lutfur Rahman M; Ito K; Furuhashi A; Hayashi T; Konishi H; Tsuzuki S; Hosokawa Y; Kazaoka Y
Cancer Med; 2020 Apr; 9(8):2904-2917. PubMed ID: 32096304
[TBL] [Abstract] [Full Text] [Related]
16. Biallelic PTCH1 Inactivation Is a Dominant Genomic Change in Sporadic Keratocystic Odontogenic Tumors.
Stojanov IJ; Schaefer IM; Menon RS; Wasman J; Gokozan HN; Garcia EP; Baur DA; Woo SB; Sholl LM
Am J Surg Pathol; 2020 Apr; 44(4):553-560. PubMed ID: 31725470
[TBL] [Abstract] [Full Text] [Related]
17. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
[TBL] [Abstract] [Full Text] [Related]
18. miR-370 inhibits the angiogenic activity of endothelial cells by targeting smoothened (smo) and bone morphogenetic protein (BMP)-2.
Gu Y; Becker V; Zhao Y; Menger MD; Laschke MW
FASEB J; 2019 Jun; 33(6):7213-7224. PubMed ID: 30865837
[TBL] [Abstract] [Full Text] [Related]
19. The Mutational Profile of Unicystic Ameloblastoma.
Heikinheimo K; Huhtala JM; Thiel A; Kurppa KJ; Heikinheimo H; Kovac M; Kragelund C; Warfvinge G; Dawson H; Elenius K; Ristimäki A; Baumhoer D; Morgan PR
J Dent Res; 2019 Jan; 98(1):54-60. PubMed ID: 30216733
[TBL] [Abstract] [Full Text] [Related]
20. The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis.
Kramann R; Schneider RK
Blood; 2018 May; 131(19):2111-2119. PubMed ID: 29572380
[TBL] [Abstract] [Full Text] [Related]
[Next]
